tirzepatide legal team in kentucky bill to tighten oversight of compounded weight loss drugs Doctor Prescribing Zepbound in Kentucky

This variability underscores why personalized medicinerather than population averagesshould guide your treatment plan

And in a recent survey of state Medicaid directors conducted by KFF, a health policy research organization, they said cost and potential side effects are among their concerns

Understanding your dosage and frequency is key to establishing optimal B12 levels

Lilly finished the third quarter with a combined $4.37 billion in sales for its two GLP-1 products based on the same active ingredient tirzepatidethe type 2 diabetes treatment Mounjaro and obesity drug Zepbound Mounjaro accounted for $3.112 billion of those Q3 sales, with Zepbound racking up the remaining $1.258 billion

The individual and socioeconomic impact of osteoarthritis